Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing Remitting Multiple Sclerosis (RRMS)”

186 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 186 results

Large-scale testing (Phase 3)UnknownNCT02220244
What this trial is testing

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
MedDay Pharmaceuticals SA 105
Post-approval studies (Phase 4)Study completedNCT01333501
What this trial is testing

Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 151
Testing effectiveness (Phase 2)Study completedNCT02410200
What this trial is testing

Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 22
Not applicableStudy completedNCT03758820
What this trial is testing

Behavior Cognitive Therapy on Fatigue Impact in MS Patients

Who this might be right for
Relapsing Remitting Multiple SclerosisFatigueCognitive Therapy
Réseau Sep Idf Ouest 105
Testing effectiveness (Phase 2)Study completedNCT00882999
What this trial is testing

Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Eli Lilly and Company 245
Not applicableActive Not RecruitingNCT05811416
What this trial is testing

Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Bristol-Myers Squibb 200
Not applicableActive Not RecruitingNCT07497126
What this trial is testing

The Prevalance of Malnutrition and Its Association With Disability in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Malnutrition or Risk of Malnutrition
Antalya Training and Research Hospital 169
Not applicableStudy completedNCT01075880
What this trial is testing

Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 300
Testing effectiveness (Phase 2)Study completedNCT01717664
What this trial is testing

Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
RedHill Biopharma Limited 18
Large-scale testing (Phase 3)Study completedNCT02861014
What this trial is testing

Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Hoffmann-La Roche 681
Post-approval studies (Phase 4)WithdrawnNCT02675413
What this trial is testing

Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Washington University School of Medicine
Large-scale testing (Phase 3)Study completedNCT04115488
What this trial is testing

Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri®

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)
Polpharma Biologics S.A. 265
Not applicableStudy completedNCT00461396
What this trial is testing

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Bayer 104
Testing effectiveness (Phase 2)Study completedNCT01185821
What this trial is testing

Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 185
Not applicableStudy completedNCT03134573
What this trial is testing

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

Who this might be right for
Multiple Sclerosis
Bayer 96
Post-approval studies (Phase 4)Ended earlyNCT01436643
What this trial is testing

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Who this might be right for
DepressionRelapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 54
Testing effectiveness (Phase 2)Study completedNCT01742052
What this trial is testing

Dose-finding Study of MT-1303

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Tanabe Pharma Corporation 415
Early research (Phase 1)Ended earlyNCT01318421
What this trial is testing

ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Elan Pharmaceuticals 12
Large-scale testing (Phase 3)Study completedNCT01307332
What this trial is testing

Advanced MRI Measures of Repair in Alemtuzumab Treated Patients

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University of British Columbia 27
Large-scale testing (Phase 3)Study completedNCT05242133
What this trial is testing

Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Cinnagen 168
Next Page